This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2007 Sep;6(3):293-6.

doi: 10.1177/1534735407306358.

Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone

Burton M Berkson¹, Daniel M Rubin, Arthur J Berkson

Affiliations

PMID: 17761642
DOI: 10.1177/1534735407306358

Free article

Case Reports

Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone

Burton M Berkson et al. Integr Cancer Ther. 2007 Sep.

Free article

. 2007 Sep;6(3):293-6.

doi: 10.1177/1534735407306358.

Authors

Burton M Berkson¹, Daniel M Rubin, Arthur J Berkson

Affiliation

¹ Integrative Medical Center of New Mexico, Las Cruces, USA.

PMID: 17761642
DOI: 10.1177/1534735407306358

No abstract available

PubMed Disclaimer

Similar articles

ALSUntangled No. 8: Low dose naltrexone for ALS.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2011 Jan;12(1):76-8. doi: 10.3109/17482968.2010.544386. Epub 2010 Dec 21. Amyotroph Lateral Scler. 2011. PMID: 21174518 No abstract available.
[Follicular dural lymphoma. Case report].
Peltier J, Fichten A, Lefranc M, Toussaint P, Desenclos C, Pruvot AS, Nicot B, Le Gars D. Peltier J, et al. Neurochirurgie. 2009 Jun;55(3):345-9. doi: 10.1016/j.neuchi.2008.12.003. Epub 2009 May 9. Neurochirurgie. 2009. PMID: 19428037 French.
T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P, Caulet-Maugendre S, Foussard C, Salles G, Moreau A, Rossi JF, Patey M, Rousselet MC, Bene MC, Damotte D, Cornillet Lefebvre P, Martin A, Costes V; GOELAMS group. Raynaud P, et al. Hum Pathol. 2008 Feb;39(2):194-200. doi: 10.1016/j.humpath.2007.05.026. Epub 2007 Oct 18. Hum Pathol. 2008. PMID: 17949786 Clinical Trial.
Rituximab: a B-cell depletion therapy for dermatologic disease.
Prajapati V, Mydlarski PR. Prajapati V, et al. Skin Therapy Lett. 2007 Jul-Aug;12(6):6-9. Skin Therapy Lett. 2007. PMID: 17762903 Review.
Successful treatment of primary non-Hodgkin's lymphoma of the vulva with radiation therapy.
Tokatli F, F Oz-Puyan F, Alas R, Usta U, Yilmaz H, Uzal C. Tokatli F, et al. J BUON. 2009 Jan-Mar;14(1):119-22. J BUON. 2009. PMID: 19365881 Review.

See all similar articles

Cited by

Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
Belltall A, Mazzinari G, Diaz-Cambronero O, Eroles P, Argente Navarro MP. Belltall A, et al. Curr Oncol Rep. 2022 Oct;24(10):1337-1349. doi: 10.1007/s11912-022-01295-z. Epub 2022 Jun 1. Curr Oncol Rep. 2022. PMID: 35648340 Free PMC article. Review.
Naltrexone's Impact on Cancer Progression and Mortality: A Systematic Review of Studies in Humans, Animal Models, and Cell Cultures.
Liubchenko K, Kordbacheh K, Khajehdehi N, Visnjevac T, Ma F, Khan JS, Storey M, Abd-Elsayed A, Visnjevac O. Liubchenko K, et al. Adv Ther. 2021 Feb;38(2):904-924. doi: 10.1007/s12325-020-01591-9. Epub 2020 Dec 18. Adv Ther. 2021. PMID: 33337537 Review.
Impact of Opioid Use in Hematological Malignancies: Clinical, Immunological and Concomitant Aspects.
Tregubenko P, Zvonarev V. Tregubenko P, et al. J Hematol. 2020 Sep;9(3):41-54. doi: 10.14740/jh689. Epub 2020 Aug 14. J Hematol. 2020. PMID: 32855752 Free PMC article. Review.
Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.
Toljan K, Vrooman B. Toljan K, et al. Med Sci (Basel). 2018 Sep 21;6(4):82. doi: 10.3390/medsci6040082. Med Sci (Basel). 2018. PMID: 30248938 Free PMC article. Review.
The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol.
Berkson BM, Calvo Riera F. Berkson BM, et al. Integr Cancer Ther. 2018 Sep;17(3):986-993. doi: 10.1177/1534735417747984. Epub 2017 Dec 19. Integr Cancer Ther. 2018. PMID: 29258346 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon